Dirui Industrial Co (300396) Fair Value & Analysis
Healthcare · CN · Market cap 1.9B CNY
Fair value as of: Jun 24, 2026
Analysis
Dirui Industrial Co (300396) currently trades at ¥6.62, while our model-based Fair Value estimate is ¥5.15 — implying the stock looks roughly 22.2% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Dirui Industrial Co., Ltd. engages in the research and development, production, and sale of medical inspection products in the People's Republic of China. The company provides medical instruments and supporting test strip reagents. It also offers urine and biochemical analysis, chemiluminescence immunoassay, gynecological secretion analysis, blood cell analysis, coagulation analysis, and integrated laboratory products. In addition, the company provides molecular diagnostics, veterinary, hematology, and SARS-CoV-2 products. Dirui Industrial Co.,Ltd. was founded in 1992 and is headquartered in Changchun, the People's Republic of China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Dirui Industrial Co (300396) undervalued?
What is the fair value of 300396?
What is the quality score of 300396?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.